AzTrials
AzTrials

Immobility and Weakness Associated With Long Intensive Care Unit StaysNCT01295541

Early Progressive Mobility in the CVICU: Assessing Current Status

An observational study of Immobility and Weakness Associated With Long Intensive Care Unit Stays, run by Hill-Rom at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study is proposed to assess the frequency and type of progressive mobility procedures currently performed in the CVICU The study will evaluate the type and frequency of progressive mobility orders, whether or not progressive mobility steps are being taken by the nursing teams, define what steps patients… Read more about this study

Who is it for?
Ages 18 years and older
How many people
10 participants
Where
1 siteUnited States
Study dates
Jul 2010to Dec 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of patients admitted to the CV-Intensive Care Unit.

Who may be able to join

  • Patient is ≥ 18 years old.
  • Patient has been admitted to the ICU for less than 3 days prior to study enrollment
  • Patients require mechanical ventilation for >48 hours

Who cannot join

  • Mobilization is contraindicated by Patient's condition. Such as hip fractures or other injury that would impede standing posture.
  • Patient weighs less than 70 pounds or more than 440 pounds
  • Mobilization is contraindicated by patient's condition or physician's orders exist that prevent the patient from participating in the mobility protocol.
  • Patient was unable to walk or stand without assistance prior to ICU admission.
  • Patient was cognitively unable to follow verbal commands prior to ICU admission.
  • Patients current diagnosis includes acute stroke with neurologic impairment
Show all 9Show fewer
  • Patient's current diagnosis includes drug overdose.
  • Patient has "Do not resuscitate" orders and/or is at an end stage terminal disease state.
  • Patient requires a specialty bed or mattress.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Medical College of Central Georgia

    Macon, Georgia, 31201

Other trials in United States

About this study

The current study is proposed to assess the frequency and type of progressive mobility procedures currently performed in the CVICU The study will evaluate the type and frequency of progressive mobility orders, whether or not progressive mobility steps are being taken by the nursing teams, define what steps patients are receiving, and record time to first weight bearing. Other outcome measures will be the days of required mechanical ventilation, and current ICU length of stay and cost to treat.

Read the detailed description

This will be a descriptive 4 month study of standard care practice. Patients who meet the inclusion / exclusion criteria for study will be enrolled (Waiver of informed consent is requested) and followed for a maximum of 28 days. The type and frequency of progressive mobility orders, whether or not progressive mobility steps are being taken by the nursing teams, define what steps patients are receiving, and record time to first weight bearing will be recorded. Weight bearing will be defined as standing for at least 1 minute. ICU LOS, Ventilator Days will be assessed at ICU discharge for study patients. Barriers to PM procedures will also be assessed.

Keywords
ICU LOS, Progressive Mobility, Deconditioning

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01295541
Study groupRoleWhat they receive
4 months of observationCVICU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First OOB

    The ICU day that the patient is able to stand for at least 1 minute will be assessed.

    Measured: Days

Secondary outcomes (2)
  1. ICU LOS

    Length of stay will be measured

    Measured: Days

  2. Type and Frequency of PM orders

    The type and frequency of Progressive mobility orders will be assessed

    Measured: Daily

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2011 (estimated)
  2. Study startJul 2010
  3. Primary completionDec 2010
  4. Study completionDec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01295541
Sponsor's protocol ID
CR-2009-05a
Status last verified
Feb 2011
First submitted
6 Jul 2010
Last updated
14 Feb 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Immobility and Weakness Associated With Long Intensive Care Unit Stays, run by Hill-Rom at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Feb 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First OOB (time frame: Days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2011.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in